Akebia Therapeutics, Inc.AKBANASDAQ
Loading
EBITDA as a percentage of revenue
| Period | Value | YoY Change |
|---|---|---|
| TTM | 9.20% | +207.4% |
| 2024 | -8.57% | -101.7% |
| 2023 | -4.25% | -506.5% |
| 2022 | 1.04% | +101.2% |
| 2021 | -89.73% | -89.1% |
| 2020 | -47.46% | +36.4% |
| 2019 | -74.59% | +13.0% |
| 2018 | -85.73% | -100.6% |
| 2017 | -42.73% | +99.5% |
| 2016 | -8870.62% | - |